Pediatrics
Showing 81-100 of 539 Results
-
Mary M. Chen, MS, MBA
Executive Director, Maternal & Child Health Research Institute, Pediatrics
Current Role at StanfordAssistant Dean of Maternal and Child Health Research; Executive Director of the Stanford Child Health Research Institute.
-
Patrisha Cherry
Adm Svcs Admstr 1, Pediatrics - Neonatology
Current Role at StanfordAs a Program Coordinator within the esteemed Dean of Research Division, Patrisha Ann Cherry is entrusted with the pivotal responsibility of coordinating and facilitating programs vital to Dosimetry Services and Research Safety. This role involves a multifaceted approach, requiring a keen eye for detail, strategic planning, and proactive problem-solving.
Key Responsibilities and Contributions:
Dosimetry Services Oversight:
Acting as a linchpin between the division and Dosimetry Services, Patrisha skillfully manages and oversees operational intricacies. This includes aligning programs with organizational priorities, ensuring compliance with established protocols, and optimizing Dosimetry Services to meet healthcare institutions' diverse needs.
Research Safety Coordination:
Demonstrating an acute understanding of research safety imperatives, Patrisha plays a central role in coordinating safety measures within the research domain. This entails liaising with stakeholders, instituting safety protocols, and fostering a culture of safety consciousness that permeates throughout the research community.
Administrative Excellence:
In the capacity of a Program Coordinator, Patrisha acts on behalf of the supervisor and department manager to establish priorities and address administrative challenges. With a focus on streamlined operations, she adeptly plans and schedules calendars, resolving conflicts efficiently and ensuring compliance with organizational policies.
Document Management and Editing:
Patrisha exhibits exceptional prowess in composing, drafting, and editing a wide array of documents. Whether it's presentations, grants, course handouts, or reports, she ensures accuracy and clarity, maintaining a high standard in all organizational communications.
Financial Transactions and Budget Oversight:
With a strong financial acumen, Patrisha effectively manages and processes a variety of complex financial transactions within the Dosimetry Services and Research Safety domains. She monitors and reconciles budget statements, providing valuable insights to uphold fiscal integrity.
Educational Background:
Bachelor of Science in Psychology and Social Actions
Palo Alto University, Palo Alto (August 2017 - September 2019)
Professional Development:
Master of Public Health (MPH) - In Progress
University of California, Berkeley, Berkeley (Expected Completion: Spring 2024)
Additional Attributes:
Committed to the diversity, inclusion, equitable and respectful provision of care and working with communities of color. -
Megan Christofferson
Department Fellowship Manager, Pediatrics
Current Role at StanfordFellowship Coordinator, Pediatric Gastroenterology
Fellowship Coordinator, Pediatric Transplant Hepatology -
Pasqualina Colella
Senior Research Scientist, Pediatrics - Genetics
BioDr. Pasqualina Colella is a scientist with extensive expertise in preclinical gene and cell therapy for rare inherited diseases.
She is currently a Senior Research Scientist at Stanford University, where she is developing innovative cell therapy approaches to address neuropathic lysosomal storage diseases (LSDs) using hematopoietic stem cell transplantation (HSCT) and genome editing. Her particular focus is on untreatable diseases caused by progranulin deficiency.
During her PhD research at TIGEM (IT), she developed therapeutic approaches for inherited blindness caused by the degeneration of retinal photoreceptors and dual AAV-mediated large gene delivery to the retina for USHIB and STGD.
During her postdoctoral studies at Genethon (FR), Dr. Colella focused on gene therapy for diseases caused by lysosomal enzyme deficiencies, particularly Pompe disease. She addressed immune and efficacy limitations of preclinical in vivo AAV gene therapy through transgene engineering, including secretable GAA and tandem promoters, while also investigating lysosomal enzyme trafficking and immune responses to gene therapy.
Dr. Colella has a proven track record, with 30 published manuscripts (16 as first author, 6 as corresponding author) and 5 patents.
Her preclinical work laid the initial foundation for USH1B and Pompe disease clinical trials.
She is dedicated to driving innovations in gene and cell therapy for untreatable diseases and mentoring the next generation of passionate and rigorous gene and cell therapists -
Jennifer Cory
Director of Strategy and Operations, Peds/CDCM Center for Definitive and Curative Medicine
Current Role at StanfordDirector of Strategy and Operations, Center for Definitive and Curative Medicine
-
Justin Crest
Associate Director of Team Science, Pediatrics
BioJustin is an experienced research scientist who has a passion for collaborative team science. He has recieved support from NIH, W.M. Keck, and the Damon Runyon Cancer Research Foundation for his multidisceplenary projects. At Stanford, he facilitates faculty and trainees to strategically position their grants and research goals in order to maximize funding success, while also encouraging new collaborative research within Pediatrics and campus-wide.
-
Arlene S. Cullum, MPH
Recruitment and Engagement, Pediatrics - Neonatology
Current Role at StanfordDirector of Special Projects, Department of Pediatrics, School of Medicine Stanford University
